Hair cloning

Last updated

Hair multiplication, or hair cloning, is a proposed technique to counter hair loss. The technology is in its early stages, but multiple groups have demonstrated pieces of the technology at a small scale, with a few in commercial development.

Contents

Scientists previously assumed that in the case of complete baldness, follicles are completely absent from the scalp, so they cannot be regenerated. However, the follicles are not entirely absent, as there are stem cells in the bald scalp from which the follicles naturally arise. The behavior of these follicles is suggested to be the result of progenitor cell deficiency in these areas.

The basic idea of hair cloning is that healthy follicle cells or dermal papillae can be extracted from the subject from areas that are not bald and are not suffering hair loss. They can be multiplied (cloned) by various culturing methods [1] and the new cells can be injected back into the bald scalp, where they would produce healthy hair.

Research

Early trials

One of the first companies to begin experimenting with hair cloning was Intercytex. [2] Intercytex tried to clone new hair follicles from the stem cells harvested from the back of the neck. They hoped that if they multiplied the follicles and then implanted them back in the scalp in the bald areas, they would be successful in regrowing the hair itself. [3] In 2008, Intercytex interpreted that they failed in fully developing the hair cloning therapy and decided to discontinue all research. [3]

The first time scientists were able to grow artificial hair follicles from stem cells was in 2010. Scientists at the Technische Universität Berlin in Germany, with Intercytex and several other research teams, took animal cells and created follicles by using them. As a result, they produced follicles "thinner than normal". They were able to clone one or two follicles from an extracted hair.

Aderans Research Institute, a Japanese company, worked on what they called the "Ji Gami" process, which involved the removal of a small strip of the scalp, which is broken down into individual follicular stem cells. After the extraction, these cells are cultured and injected back into the bald areas of the scalp.[ citation needed ] The trials continued in 2012. Aderans decided to discontinue the funding of its hair multiplication research in July 2013. [4] [ better source needed ]

University of Pennsylvania

In 2012, scientists from the University of Pennsylvania School of Medicine published their own findings regarding hair cloning. [5] During their investigation, they found that non-bald and bald scalps have the same number of stem cells, but the progenitor cell number was significantly depleted in the case of the latter. Based on this, they concluded that it is not the absence of the stem cells that are responsible for hair loss but the unsuccessful activation of said cells. [6]

Development

In 2015, initial trials for human hair were successful in generating new follicles, [7] but the hairs grew in varying directions.

In 2016, scientists in Japan announced they had successfully grown human skin in a lab. [8] The skin was created using induced pluripotent stem cells, and when implanted in a mouse, the skin grew hairs successfully. The group has formed partnerships with Organ Technologies and Kyocera Corporation to commercially develop the research. [9]

dNovo Bio, a Silicon Valley–based company, was founded in 2018 and has demonstrated growing a patch of human hair on a mouse. [10] [ better source needed ] In July 2019, a researcher from San Diego–based Stemson Therapeutics, partnered with UCSD, successfully grew his own follicles on a mouse using iPSC-derived epithelial and dermal cell therapy. The hair was aligned properly with a 3D-printed biodegradable shaft. The hairs were permanent and regenerated naturally. [11] Stemson intends to enter clinical trials in 2026. [12]

In October 2022, researchers from the Japan-based Yokohama National University successfully cloned fully-grown mouse hair follicles for the first time in history. [13]

See also

Related Research Articles

<span class="mw-page-title-main">Human cloning</span> Creation of a genetically identical copy of a human

Human cloning is the creation of a genetically identical copy of a human. The term is generally used to refer to artificial human cloning, which is the reproduction of human cells and tissue. It does not refer to the natural conception and delivery of identical twins. The possibilities of human cloning have raised controversies. These ethical concerns have prompted several nations to pass laws regarding human cloning.

<span class="mw-page-title-main">Stem cell</span> Undifferentiated biological cells that can differentiate into specialized cells

In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can change into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell in a cell lineage. They are found in both embryonic and adult organisms, but they have slightly different properties in each. They are usually distinguished from progenitor cells, which cannot divide indefinitely, and precursor or blast cells, which are usually committed to differentiating into one cell type.

<span class="mw-page-title-main">Hair loss</span> Loss of hair from the head or body

Hair loss, also known as alopecia or baldness, refers to a loss of hair from part of the head or body. Typically at least the head is involved. The severity of hair loss can vary from a small area to the entire body. Inflammation or scarring is not usually present. Hair loss in some people causes psychological distress.

<span class="mw-page-title-main">Hair follicle</span> Organ found in mammalian skin

The hair follicle is an organ found in mammalian skin. It resides in the dermal layer of the skin and is made up of 20 different cell types, each with distinct functions. The hair follicle regulates hair growth via a complex interaction between hormones, neuropeptides, and immune cells. This complex interaction induces the hair follicle to produce different types of hair as seen on different parts of the body. For example, terminal hairs grow on the scalp and lanugo hairs are seen covering the bodies of fetuses in the uterus and in some newborn babies. The process of hair growth occurs in distinct sequential stages: anagen is the active growth phase, catagen is the regression of the hair follicle phase, telogen is the resting stage, exogen is the active shedding of hair phase and kenogen is the phase between the empty hair follicle and the growth of new hair.

The management of hair loss, includes prevention and treatment of alopecia, baldness, and hair thinning, and regrowth of hair.

<span class="mw-page-title-main">Regenerative medicine</span> Field of medicine involved in regenerating tissues

Regenerative medicine deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.

<span class="mw-page-title-main">Hair transplantation</span> Surgical operation to relocate hair follicles

Hair transplantation is a surgical technique that removes hair follicles from one part of the body, called the 'donor site', to a bald or balding part of the body known as the 'recipient site'. The technique is primarily used to treat male pattern baldness. In this minimally invasive procedure, grafts containing hair follicles that are genetically resistant to balding are transplanted to the bald scalp.

<span class="mw-page-title-main">Pattern hair loss</span> Medical condition

Pattern hair loss is a hair loss condition that primarily affects the top and front of the scalp. In male-pattern hair loss (MPHL), the hair loss typically presents itself as either a receding front hairline, loss of hair on the crown and vertex of the scalp, or a combination of both. Female-pattern hair loss (FPHL) typically presents as a diffuse thinning of the hair across the entire scalp.

Follicular unit extraction is one of two primary methods of obtaining hair follicles, naturally occurring groups of one to four hairs, for hair transplantation. The other method is called strip harvesting. In 2018, Mejia published the updated guidelines adopted by the International Society of Hair Restoration Surgery. This name change came about to accurately describe the procedure which involves surgically cutting or incising a full thickness hair follicle skin graft with a circular scalpel, punch or motorized drill and subsequently carefully extracting it from the scalp to be placed in the donor balding scalp. Due to the new developments of incision punches and devices and a variety of different extraction techniques, it was necessary to more accurately define the procedure. Additionally, many places were incorrectly marketing the extraction procedure as a simple plucking of hairs and deceiving the public.

<span class="mw-page-title-main">DSC3</span> Protein-coding gene in the species Homo sapiens

Desmocollin-3 is a protein that in humans is encoded by the DSC3 gene.

Embryomics is the identification, characterization and study of the diverse cell types which arise during embryogenesis, especially as this relates to the location and developmental history of cells in the embryo. Cell type may be determined according to several criteria: location in the developing embryo, gene expression as indicated by protein and nucleic acid markers and surface antigens, and also position on the embryogenic tree.

Anagen effluvium is the pathologic loss of anagen or growth-phase hairs. Classically, it is caused by radiation therapy to the head and systemic chemotherapy, especially with alkylating agents.

Scarring hair loss, also known as cicatricial alopecia, is the loss of hair which is accompanied with scarring. This is in contrast to non scarring hair loss.

The growth of human hair occurs everywhere on the body except for the soles of the feet, the palms of the hands, the inside of the mouth, the lips, the backs of the ears, some external genital areas, the navel, and, apart from eyelashes, the eyelids. Hair is a stratified squamous keratinized epithelium made of multi-layered flat cells whose rope-like filaments provide structure and strength to the hair shaft. The protein called keratin makes up hair and stimulates hair growth. Hair follows a specific growth cycle with three distinct and concurrent phases: anagen, catagen, and telogen. Each phase has specific characteristics that determine the length of the hair.

Regeneration in humans is the regrowth of lost tissues or organs in response to injury. This is in contrast to wound healing, or partial regeneration, which involves closing up the injury site with some gradation of scar tissue. Some tissues such as skin, the vas deferens, and large organs including the liver can regrow quite readily, while others have been thought to have little or no capacity for regeneration following an injury.

Valerie Horsley is an American cell and developmental biologist. She currently works as an associate professor at Yale University, where she has extensively researched the growth, restoration, and maintenance of skin cells. She is a currently a member of the Yale Cancer Center and Yale Stem Cell Center. She received a Presidential Early Career Award for Scientists and Engineers in 2012 and in 2013 she was the recipient of the Rosalind Franklin Young Investigator Award.

RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.

Protein Transduction Domain-fused Dishevelled Binding Motif (PTD-DBM) is a man-made peptide which interacts with the mechanism of the hair loss linked endogenous protein, CXXC5, which is a negative feedback regulator of the Wnt/β-catenin pathway. Application of the peptide to bald laboratory mice resulted in new hair follicle growth.

<span class="mw-page-title-main">Cheng-Ming Chuong</span>

Cheng-Ming Chuong is a Taiwanese-American biomedical scientist.

Angela M. Christiano is a molecular geneticist in the field of dermatology. Her research focuses on genes involved in hair and skin growth, as well as treatments for hair loss and skin cancers. She is the Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics and Development at Columbia University Vagelos College of Physicians and Surgeons.

References

  1. "Methods of Hair cloning". hairforlife.info. 21 July 2020. Retrieved 21 July 2020.
  2. "Hair Care and Trichology | Health Articles | The Future of Hair Restoration". Worldwidehealth.com. 31 January 2014. Retrieved 5 February 2014.
  3. 1 2 "Detail How Intercytex Failed Fully In Developing Hair Cloning Therapy". HD Hairlines. Retrieved 12 February 2023.
  4. "Aderans to no Longer Fund its Hair Multiplication Research | Hair Loss Q & A". Regrowhair.com. 30 July 2013. Retrieved 5 February 2014.
  5. "Perelman School of Medicine Experts Identify Inhibitor Causing Male Pattern Baldness and Target for Hair Loss Treatments". Penn Medicine News. 21 March 2012.
  6. Chueh SC, Lin SJ, Chen CC, Lei M, Wang LM, Widelitz R, et al. (March 2013). "Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering". Expert Opinion on Biological Therapy. 13 (3): 377–391. doi:10.1517/14712598.2013.739601. PMC   3706200 . PMID   23289545.
  7. "Grow New Follicles". columbia.edu. 14 December 2013. Retrieved 21 July 2020.
  8. Takagi R, Ishimaru J, Sugawara A, Toyoshima KE, Ishida K, Ogawa M, et al. (April 2016). "Bioengineering a 3D integumentary organ system from iPS cells using an in vivo transplantation model". Science Advances. 2 (4): e1500887. Bibcode:2016SciA....2E0887T. doi:10.1126/sciadv.1500887. PMC   4820374 . PMID   27051874.
  9. "Kyocera Corporation, RIKEN And Organ Technologies Launch Joint Research In Regenerative Medicine To Treat Hair Loss". BioSpace. Retrieved 3 October 2022.
  10. "Going bald? Lab-grown hair cells could be on the way". MIT Technology Review. Retrieved 3 October 2022.
  11. Prebys, Sanford Burnham (27 June 2019). "Functional hair follicles grown from stem cells". Eurekalert.
  12. "Hair Cloning Research And Progress 2023 – Follicle Thought" . Retrieved 9 January 2024.
  13. Kageyama T, Shimizu A, Anakama R, Nakajima R, Suzuki K, Okubo Y, Fukuda J (October 2022). "Reprogramming of three-dimensional microenvironments for in vitro hair follicle induction". Science Advances. 8 (42): eadd4603. Bibcode:2022SciA....8D4603K. doi:10.1126/sciadv.add4603. PMC   9586475 . PMID   36269827.

Further reading